This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
$0.25
Share price
4.59%
Change (1 day)
-75.19%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): $0.66 Million USD
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is $0.66 Million USD. In 2023 the company made a revenue of $0.01 Million USD a decrease over the revenue in the year 2022 that were of $0.26 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | $0.66 M | 4440.86% |
| 2023 | $0.01 M | -94.46% |
| 2022 | $0.26 M | |
| 2021 | N/A | -100% |
| 2020 | $0.03 M | -98.81% |
| 2019 | $2.68 M | -3.35% |
| 2018 | $2.77 M | -32.74% |
| 2017 | $4.13 M | -20.8% |
| 2016 | $5.21 M | 2.56% |
| 2015 | $5.08 M | -71.78% |
| 2014 | $18.02 M | 1104.64% |
| 2013 | $1.49 M | 29.74% |
| 2012 | $1.15 M | -66.11% |
| 2011 | $3.4 M | 35.15% |
| 2010 | $2.51 M | -13.48% |
| 2009 | $2.91 M | 169.83% |
| 2008 | $1.07 M | 55.88% |
| 2007 | $0.69 M | 42.82% |
| 2006 | $0.48 M | 114.87% |
| 2005 | $0.22 M | |
| 2004 | N/A | -100% |
| 2003 | $0.68 M | -24.09% |
| 2002 | $0.9 M | 195.12% |
| 2001 | $0.3 M |